Literature DB >> 7813427

Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.

C Abramovich1, L M Shulman, E Ratovitski, S Harroch, M Tovey, P Eid, M Revel.   

Abstract

The human interferon alpha-receptor (IFNAR gene product) is a transmembranal protein of 557 amino acids with an intracytoplasmic domain of 100 amino acids containing four tyrosines. Antibodies to a C-terminal peptide (residues 521-536) were developed which efficiently immunoprecipitate the 105 kDa IFNAR protein from detergent extracts of human cells. We show that the IFNAR protein becomes tyrosine phosphorylated within 5 min after treatment of human myeloma U266 cells with IFN-alpha 2, IFN-alpha 8 or IFN-beta. The IFNAR chain interacts with both IFN-alpha 2 and IFN-beta, as demonstrated by cross-linking. Among elements involved in signal transduction by type I IFNs, the tyrosine kinase Tyk2 but not Jak1, and the ISGF3 transcription factor subunit Stat2 (p113) but not Stat1 (p91), are found associated with the IFNAR protein. After IFN-beta treatment for 5 min, a tyrosine-phosphorylated protein of approximately 95 kDa (beta-PTyr) is found bound to IFNAR, but can be dissociated by denaturation. The beta-PTyr protein is present on the cell surface, like IFNAR, as shown by extracellular biotin tagging. The ratio of beta-PTyr to IFNAR tyrosine phosphorylation is much higher with IFN-beta than with IFN-alpha 2 or 8. Both are IFN dependent and abrogated by a monoclonal antibody which blocks IFNAR action. The beta-PTyr component may represent an important difference in the action of IFN-beta as compared with IFN-alpha in their shared receptor system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813427      PMCID: PMC395562          DOI: 10.1002/j.1460-2075.1994.tb06932.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

Authors:  L Velazquez; M Fellous; G R Stark; S Pellegrini
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

Review 2.  Structure of the human interferon alpha receptor.

Authors:  O R Colamonici; L M Pfeffer
Journal:  Pharmacol Ther       Date:  1991-11       Impact factor: 12.310

3.  A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.

Authors:  P Benoit; D Maguire; I Plavec; H Kocher; M Tovey; F Meyer
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

4.  Evidence for multiple binding sites for several components of human lymphoblastoid interferon-alpha.

Authors:  R Hu; Y Gan; J Liu; D Miller; K C Zoon
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

5.  Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21.

Authors:  O R Colamonici; P Domanski
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

6.  Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor.

Authors:  L C Platanias; O R Colamonici
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

7.  Multichain structure of the IFN-alpha receptor on hematopoietic cells.

Authors:  O R Colamonici; L M Pfeffer; F D'Alessandro; L C Platanias; S A Gregory; A Rosolen; R Nordan; R A Cruciani; M O Diaz
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

8.  Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta.

Authors:  T G Johns; I R Mackay; K A Callister; P J Hertzog; R J Devenish; A W Linnane
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

9.  Soluble interferon-alpha receptor molecules are present in body fluids.

Authors:  D Novick; B Cohen; M Rubinstein
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

10.  The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction.

Authors:  X Y Fu; C Schindler; T Improta; R Aebersold; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  39 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Authors:  Lorraine Tracey; Raquel Villuendas; Pablo Ortiz; Ana Dopazo; Inmaculada Spiteri; Luis Lombardia; Jose L Rodríguez-Peralto; Jesús Fernández-Herrera; Almudena Hernández; Javier Fraga; Orlando Dominguez; Javier Herrero; Miguel A Alonso; Joaquin Dopazo; Miguel A Piris
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  IFNalpha/beta promotes cell survival by activating NF-kappa B.

Authors:  C H Yang; A Murti; S R Pfeffer; L Basu; J G Kim; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 4.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

5.  Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice.

Authors:  Fulvia Terenzi; Christine White; Srabani Pal; Bryan R G Williams; Ganes C Sen
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  IFN-β-specific signaling via a unique IFNAR1 interaction.

Authors:  Surinder Kaur; Leonidas C Platanias
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

7.  Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.

Authors:  Julie Claudinon; Pauline Gonnord; Emilie Beslard; Marta Marchetti; Keith Mitchell; Cédric Boularan; Ludger Johannes; Pierre Eid; Christophe Lamaze
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 8.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

9.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.

Authors:  X Q Qin; N Tao; A Dergay; P Moy; S Fawell; A Davis; J M Wilson; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.